An enlarged prostate does not automatically mean cancer, but urinary symptoms can overlap across several conditions. Learn ...

Butterfly Medical, developer of a proprietary minimally invasive solution for benign prostatic hyperplasia (BPH), today announced that it has received certification under the European Union Medical ...

Boost ROI by targeting minimally invasive BPH devices, outpatient care and Asia-Pacific expansion while investing in innovation, physician training and strategic partnerships.Dublin, Oct. 13, 2026 ...

Butterfly Medical, developer of a minimally invasive solution for benign prostatic hyperplasia (BPH), has earned EU MDR ...

In March 2026, Prodeon Medical has obtained U.S. Food and Drug Administration ( FDA) 510 (k) clearance for its Urocross ...

Introduction: Do not endure frequent urinationWaking up multiple times at night to use the toilet, weak urine flow, and the ...

We are proud and excited to present this special edition and joint endeavor from the Society of Benign Prostate Disease (SoBPD) and Prostate Cancer and ...

PROCEPT BioRobotics’ Aquablation may ease BPH symptoms while preserving function. Read here for a detailed investment ...

Zenflow’s Spring implant, designed to treat the symptoms of benign prostatic hyperplasia (BPH), secured FDA clearance in December 2025.

Watson-Marlow's Rodd Turnquist explains how peristaltic pumps enable robotic surgery, delivering automated irrigation, ...

Butterfly Medical, developer of a proprietary minimally invasive solution for benign prostatic hyperplasia (BPH), has ...

Learn how berberine may affect kidney function, diabetic kidney disease, inflammation, and CKD risks, plus key safety and drug interaction concerns.